v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 13,390 $ 13,054
General and administrative 6,909 4,912
Total operating expenses 20,299 17,966
Loss from operations (20,299) (17,966)
Interest income 1,982 1,333
Net loss $ (18,317) $ (16,633)
Net loss per share - basic and diluted (in dollars per share) $ (0.1) $ (0.12)
Basic and diluted weighted average shares outstanding (in shares) 186,400 138,236
Other comprehensive loss:    
Net loss $ (18,317) $ (16,633)
Unrealized gain on marketable securities (439) (20)
Comprehensive loss $ (18,756) $ (16,653)